NO954494L - MTS-gen, mutasjoner deri og metoder for diagnose av kreft ved bruk av MTS-gen-sekvens - Google Patents

MTS-gen, mutasjoner deri og metoder for diagnose av kreft ved bruk av MTS-gen-sekvens

Info

Publication number
NO954494L
NO954494L NO954494A NO954494A NO954494L NO 954494 L NO954494 L NO 954494L NO 954494 A NO954494 A NO 954494A NO 954494 A NO954494 A NO 954494A NO 954494 L NO954494 L NO 954494L
Authority
NO
Norway
Prior art keywords
mts gene
mutations
diagnosis
cancer
methods
Prior art date
Application number
NO954494A
Other languages
English (en)
Norwegian (no)
Other versions
NO954494D0 (no
Inventor
Alexander Kamb
Original Assignee
Myriad Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc filed Critical Myriad Genetics Inc
Publication of NO954494D0 publication Critical patent/NO954494D0/no
Publication of NO954494L publication Critical patent/NO954494L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO954494A 1994-03-18 1995-11-08 MTS-gen, mutasjoner deri og metoder for diagnose av kreft ved bruk av MTS-gen-sekvens NO954494L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21458194A 1994-03-18 1994-03-18
US21458294A 1994-03-18 1994-03-18
US21508894A 1994-03-18 1994-03-18
US22736994A 1994-04-14 1994-04-14
US25193894A 1994-06-01 1994-06-01
PCT/US1995/003316 WO1995025429A1 (fr) 1994-03-18 1995-03-17 Gene mts, mutations desdits genes et procedes de diagnostic du cancer a l'aide de sequences du gene mts

Publications (2)

Publication Number Publication Date
NO954494D0 NO954494D0 (no) 1995-11-08
NO954494L true NO954494L (no) 1996-01-17

Family

ID=27539686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954494A NO954494L (no) 1994-03-18 1995-11-08 MTS-gen, mutasjoner deri og metoder for diagnose av kreft ved bruk av MTS-gen-sekvens

Country Status (9)

Country Link
EP (1) EP0708592A4 (fr)
JP (1) JPH08510651A (fr)
CN (1) CN1128935A (fr)
AU (1) AU694502B2 (fr)
CA (1) CA2162147A1 (fr)
FI (1) FI955415A (fr)
NO (1) NO954494L (fr)
NZ (1) NZ283539A (fr)
WO (1) WO1995025429A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019369A1 (fr) 1994-01-14 1995-07-20 Vanderbilt University Procede de detection et de traitement du cancer du sein
US6689561B1 (en) * 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
NZ313828A (en) 1995-07-17 1999-02-25 Univ Texas Expression constructs containing the encoding region of p16 and its regulatory elements and their application in cancer therapy e.g. a replication deficient adenviral vector containing p16
US7163925B1 (en) 1995-07-17 2007-01-16 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
US6586203B1 (en) 1995-09-27 2003-07-01 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US5723313A (en) 1995-09-27 1998-03-03 St. Jude Children's Research Hospital ARF-p19, a novel regulator of the mammalian cell cycle
US6407062B1 (en) 1995-09-27 2002-06-18 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US6037121A (en) * 1995-12-08 2000-03-14 University Technologies International Inc. DNA sequence encoding a tumor suppressor gene
US6747133B1 (en) 1995-12-08 2004-06-08 University Technologies International Inc. Antibodies against the tumor suppressor gene ING1
US6117633A (en) 1995-12-08 2000-09-12 University Technologies International Inc. DNA sequence encoding the tumor suppressor gene ING1
US6143522A (en) * 1995-12-08 2000-11-07 University Technologies International, Inc. Methods of modulating apoptosis
US5672508A (en) * 1996-01-23 1997-09-30 Mitotix, Inc. Inhibitors of cell-cycle progression, and uses related thereto
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
AU2383897A (en) * 1996-04-04 1997-10-29 K.U. Leuven Research & Development New member of the multiple-tumor aberrant growth gene family
US5876972A (en) * 1996-09-23 1999-03-02 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
AU6580598A (en) * 1997-03-21 1998-10-20 Board Of Regents, The University Of Texas System (noey2) gene compositions and methods of use
US6177410B1 (en) 1997-12-05 2001-01-23 Vanderbilt University Therapeutic methods for prostate cancer
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
WO2002006481A1 (fr) * 2000-07-14 2002-01-24 Japan Science And Technology Corporation Cible d'un agent anticancereux
RU2484096C1 (ru) * 2012-02-08 2013-06-10 Общество с ограниченной ответственностью "Технофарма" ОДНОДОМЕННОЕ АНТИТЕЛО, СПЕЦИФИЧЕСКИ СВЯЗЫВАЮЩЕЕ БЕЛОК S100A4/Mts1, ПРИМЕНЕНИЕ ПОЛУЧЕННОГО АНТИТЕЛА ДЛЯ ДЕТЕКЦИИ ЭТОГО БЕЛКА
RU2732769C1 (ru) * 2020-01-10 2020-09-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования высокого риска рецидива у пациенток с IB стадией рака шейки матки, получивших комбинированное лечение
CN114163510A (zh) * 2021-03-24 2022-03-11 深圳市新靶向生物科技有限公司 一种与肝癌驱动基因突变相关的抗原肽组合及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3398149B2 (ja) * 1990-07-09 2003-04-21 リサーチ コーポレーション テクノロジーズ インコーポレーテッド Mts―1遺伝子による転移性の癌の診断
PT665886E (pt) * 1992-10-16 2003-10-31 Cold Spring Harbor Lab Rearranjo de complexos de ciclina e suas utilizacoes
US6211334B1 (en) * 1992-10-16 2001-04-03 Cold Spring Harbor Cell-cycle regulatory proteins, and uses related thereto
US6689561B1 (en) * 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment

Also Published As

Publication number Publication date
AU2186395A (en) 1995-10-09
FI955415A (fi) 1996-01-09
CA2162147A1 (fr) 1995-09-28
AU694502B2 (en) 1998-07-23
NZ283539A (en) 1998-02-26
NO954494D0 (no) 1995-11-08
FI955415A0 (fi) 1995-11-10
JPH08510651A (ja) 1996-11-12
EP0708592A4 (fr) 1997-05-07
EP0708592A1 (fr) 1996-05-01
CN1128935A (zh) 1996-08-14
WO1995025429A1 (fr) 1995-09-28

Similar Documents

Publication Publication Date Title
NO954494L (no) MTS-gen, mutasjoner deri og metoder for diagnose av kreft ved bruk av MTS-gen-sekvens
NO20013002L (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
DK0972201T3 (da) Forbindelser til immundiagnosticering af prostatacancer og fremgangsmåder til anvendelse heraf
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
NO20010196D0 (no) Sammensetninger og fremgangsmåter for terapi og diagnose av prostatakreft
NO996253D0 (no) Diagnostiske midler og legemidler for maligne tumorer
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO943696D0 (no) Fremgangsmåte ved ultralydavbildning
NO994009D0 (no) Gensekvensator og metoder
NO975284D0 (no) Undersökelse av en gjenstand ved hjelp av ultralyd
NO995690D0 (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
AU2387900A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
DE69926685D1 (de) Toner und Bildherstellungsverfahren
NO985687D0 (no) Anordning og fremgangsmÕte for gjennomlysing av fekalt skjulte blodpr°ver
DE69523362D1 (de) Bilderzeugungsverfahren und Prozesskassette
DE69834986D1 (de) Toner und Bildherstellungsverfahren
EP0974842A4 (fr) Reactif permettant d'etudier l'agglutination d'un virus et materiel destine a l'etude du virus
GB9811598D0 (en) Diagnosis and treatment of cancer
NO996467D0 (no) Fremgangsmåte for fremstilling av tiazofurin og andre C- nukleosider
AU1623899A (en) Methods of using probes for analyzing polynucleotide sequence
AU4150999A (en) Method and kit for early diagnosis of cancer
NO981662D0 (no) Diagnosering av disponerhet for kreft og behandling av dette
KR960007615A (ko) 치료 및 진단용 핵산-결합 올리고머
NO951479L (no) Fremgangsmate og anordning ved oppankret fartoy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application